Cross-regulation between FOXA1 and ErbB2 Signaling in Estrogen Receptor-Negative Breast Cancer

作者: Ali Naderi , Michelle Meyer , Dennis H. Dowhan

DOI: 10.1593/NEO.12294

关键词: Apocrine CellSignal transductionApocrineGene signatureCancer researchTranscription factorFOXA1RELBCorepressorBiology

摘要: Molecular apocrine is a subtype of estrogen receptor-negative (ER.) breast cancer, which characterized by steroid-response gene signature that includes androgen receptor, FOXA1, and high frequency ErbB2 overexpression. In this study, we demonstrate there strong association between the overexpression FOXA1 in ER- tumors. This has led us to identify cross-regulation network signaling cancer. We present two mechanisms explain molecular cells. one process, genes CREB1 c-Fos regulate transcription, another AP2α regulates expression both ErbB2. Moreover, turn, transcription genes. core shared across cell lines. Importantly, most upregulated (RELB) downregulated (PAK1) are direct targets. Our data suggest acts as dual-function factor repressive function on RELB can be explained recruitment its binding partner corepressor TLE3. It notable group FOXA1-regulated vary lines leading differences functional effects extracellular signal-regulated kinase phosphorylation viability these study demonstrates connects some key pathways

参考文章(59)
Kee Ming Chia, Ji Liu, Glenn D. Francis, Ali Naderi, A Feedback Loop between Androgen Receptor and ERK Signaling in Estrogen Receptor-Negative Breast Cancer Neoplasia. ,vol. 13, pp. 154- 166 ,(2011) , 10.1593/NEO.101324
P Farmer, H Bonnefoi, V Becette, M Tubiana-Hulin, P Fumoleau, D Larsimont, G MacGrogan, J Bergh, D Cameron, D Goldstein, S Duss, A-L Nicoulaz, M Fiche, C Brisken, M Delorenzi, R Iggo, Identification of molecular apocrine breast tumours by microarray analysis Breast Cancer Research. ,vol. 7, pp. 1- 1 ,(2005) , 10.1186/BCR1122
Andrea Oeckinghaus, Matthew S Hayden, Sankar Ghosh, Crosstalk in NF-κB signaling pathways Nature Immunology. ,vol. 12, pp. 695- 708 ,(2011) , 10.1038/NI.2065
Michael A Augello, Theresa E Hickey, Karen E Knudsen, FOXA1: master of steroid receptor function in cancer. The EMBO Journal. ,vol. 30, pp. 3885- 3894 ,(2011) , 10.1038/EMBOJ.2011.340
Leo A Niemeier, David J Dabbs, Sushil Beriwal, Joan M Striebel, Rohit Bhargava, Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation Modern Pathology. ,vol. 23, pp. 205- 212 ,(2010) , 10.1038/MODPATHOL.2009.159
Hosein Kouros-Mehr, Euan M. Slorach, Mark D. Sternlicht, Zena Werb, GATA-3 Maintains the Differentiation of the Luminal Cell Fate in the Mammary Gland Cell. ,vol. 127, pp. 1041- 1055 ,(2006) , 10.1016/J.CELL.2006.09.048
J. M. Bosher, T. Williams, H. C. Hurst, The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 92, pp. 744- 747 ,(1995) , 10.1073/PNAS.92.3.744
Min Ni, Yiwen Chen, Elgene Lim, Hallie Wimberly, Shannon T. Bailey, Yuuki Imai, David L. Rimm, X. Shirley Liu, Myles Brown, Targeting androgen receptor in estrogen receptor-negative breast cancer. Cancer Cell. ,vol. 20, pp. 119- 131 ,(2011) , 10.1016/J.CCR.2011.05.026
Ali Naderi, Ji Liu, Ian C. Bennett, BEX2 regulates mitochondrial apoptosis and G1 cell cycle in breast cancer. International Journal of Cancer. ,vol. 126, pp. 1596- 1610 ,(2009) , 10.1002/IJC.24866